Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
The Journal of Infectious Diseases
|
May 7, 2021
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou, Collin S Hill, Sanjay Sarkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008
Ye Ma, Fujie Zhang, Huiqin Li, et al.
AIDS Research and Human Retroviruses
|
January 10, 2020
HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi
Olubusuyi Moses Adewumi, Elena Dukhovlinova, Nathan Y Shehu, et al.
AIDS Patient Care and Stds
|
June 6, 2014
Total daily pill burden in HIV-infected patients in the southern United States
Shuntai Zhou, Kelly Martin, Amanda Corbett, et al.
Elife
|
March 15, 2023
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
Ean Spielvogel, Sook-Kyung Lee, Shuntai Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
<i>N</i><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
Durbadal Ojha, Collin S Hill, Shuntai Zhou, et al.
Plos Pathogens
|
September 30, 2024
N4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses
Durbadal Ojha, Collin S Hill, Shuntai Zhou, et al.
AIDS Research and Human Retroviruses
|
May 15, 2018
Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use
Elena Dukhovlinova, Alexey Masharsky, Aleksandra Vasileva, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes
Rachel M Burdorf, Shuntai Zhou, Claire Amon, et al.
ACS Chemical Biology
|
July 31, 2019
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance
Mina Henes, Gordon J Lockbaum, Klajdi Kosovrasti, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
The Journal of Infectious Diseases
|
May 7, 2021
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou, Collin S Hill, Sanjay Sarkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008
Ye Ma, Fujie Zhang, Huiqin Li, et al.
AIDS Research and Human Retroviruses
|
January 10, 2020
HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi
Olubusuyi Moses Adewumi, Elena Dukhovlinova, Nathan Y Shehu, et al.
AIDS Patient Care and Stds
|
June 6, 2014
Total daily pill burden in HIV-infected patients in the southern United States
Shuntai Zhou, Kelly Martin, Amanda Corbett, et al.
Elife
|
March 15, 2023
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
Ean Spielvogel, Sook-Kyung Lee, Shuntai Zhou, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2023
<i>N</i><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
Durbadal Ojha, Collin S Hill, Shuntai Zhou, et al.
Plos Pathogens
|
September 30, 2024
N4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses
Durbadal Ojha, Collin S Hill, Shuntai Zhou, et al.
AIDS Research and Human Retroviruses
|
May 15, 2018
Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use
Elena Dukhovlinova, Alexey Masharsky, Aleksandra Vasileva, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes
Rachel M Burdorf, Shuntai Zhou, Claire Amon, et al.
ACS Chemical Biology
|
July 31, 2019
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance
Mina Henes, Gordon J Lockbaum, Klajdi Kosovrasti, et al.
Page
of 6